On Monday night, a magnitude 6.6 earthquake struck Japan, leading to a tsunami warning. Fortunately, authorities reported minimal damage, and the warning was soon lifted. According to local media, there was only one minor injury involving a man who fell at his own home.
Japan, located in the Pacific Ring of Fire, experiences approximately 1,500 tremors annually. However, these quakes have a long-lasting impact on one's health—both physical and mental.
1. Wound Infections
Earthquake-related injuries range from cuts and bruises to fractures and crush injuries. If not attended to on time, these wounds can lead to infections like sepsis, tetanus, or even amputations if untreated. Regions with scarce medical resources face higher risks of untreated injuries and antimicrobial resistance. Ensuring prompt medical care and deploying teams to assess building safety is critical to preventing further injuries and fatalities.
A recent study examined infections in 225 earthquake survivors with musculoskeletal injuries treated between February and April 2023. It found that gram-negative bacteria were common in the wounds of the victims. Acinetobacter baumannii (49.4%) and enterococci (28.6%) were the most prevalent. Many pathogens were multidrug-resistant, with 76% from wound cultures and 58% from deep tissue cultures showing resistance. Common infections included surgical site infections (32.8%), urinary tract infections (5.3%), bloodstream infections (5.7%), and pneumonia (0.4%). Intensive care was required for 35.6% of patients, with a mortality rate of 2.7%.
2. Infectious Diseases
Earthquakes disrupt water supplies, leading to unsanitary conditions that spread waterborne diseases such as cholera. Meanwhile, it also pushes people to take shelters in dingy places, which can outbreaks of measles, respiratory illnesses, and parasitic infections like leishmaniasis. Cold conditions and stress suppress immunity, increasing the risk of disease spread.
3. Chronic Conditions
Access to medication and medical care is often disrupted by earthquakes. Studies show increased rates of heart attacks, strokes, and diabetes following earthquakes due to stress and disrupted routines. Destruction of health records and facilities exacerbates these issues, especially in disaster-prone regions.
4. Healthcare Disruption
Damaged medical facilities and transport links hinder healthcare delivery. Pregnant women and individuals with chronic diseases face heightened risks. Refugees and displaced populations encounter accessibility barriers to healthcare services.
5. Psychological Trauma
Survivors of these earthquakes often suffer from anxiety, depression, and Post Traumatic Stress Disorder (PTSD). Tailored mental health programs are crucial for recovery, especially for those already living in conflict zones or displacement.
On April 14 2010, a 7.1-magnitude earthquake struck Qinghai Province, China, devastating Yushu County. A psychological relief study, published in the Journal Of Affective Disorders in 2011, assessed the mental health of 505 survivors three to four months post-disaster. Using tools like the PTSD Checklist-Civilian version (PCL-C) and Hopkins Symptoms Checklist-25 (HSCL-25), the study found prevalence rates of 33.7% for probable PTSD, 43.8% for anxiety, and 38.6% for depression, with one-fifth of participants experiencing all three. Key risk factors included being female, experiencing intense fear during the quake, and having limited social support, as measured by the Perceived Social Support Scale (PSSS).
Credit: AI
After surgery, radiotherapy could significantly decrease the chances of an atypical meningioma returning, according to a new international phase 3 trial published in The Lancet.
The findings come from the ROAM/EORTC-1308 trial, the first randomised controlled trial to directly test whether patients with a completely removed atypical meningioma benefit from receiving radiotherapy or whether regular scans and observation are enough.
The results could help settle a treatment question that has remained uncertain for years.
Meningiomas are the most common brain tumours in adults. They develop from the meninges, the protective membranes surrounding the brain, and spinal cord.
An atypical meningioma is classified as a WHO grade 2 tumour. Unlike grade 1 meningiomas, that generally grow slowly, grade 2 tumours are more likely to grow again after surgery.
Even when surgeons manage to remove the entire visible tumour, microscopic tumour cells may remain, sparking a risk of recurrence.
Also read: The Gynecological Cancer Symptoms Women Often Mistake for “Normal” Ageing Like
The ROAM/EORTC-1308 trial enrolled 157 patients whose atypical meningiomas had been completely removed surgically. They were randomly assigned to either:
After a median follow-up of about five years, the difference in recurrence was significant. 14% of patients in the radiotherapy group experienced a recurrence, compared to 30% in the observation group. In other words, the risk of recurrence was reduced by nearly half with postoperative radiotherapy.
Additionally, at five years, about 80% of patients receiving radiotherapy remained free of recurrence, compared to about 64% of those who were monitored without immediate radiotherapy.
Also read: After 70% of His Tongue Was Removed For Cancer, Lawyer Regains Speech & Returns To Court
Until now, doctors have had to weigh two approaches after complete surgical removal of an atypical meningioma.
One option is to give radiotherapy immediately, hoping to destroy microscopic tumour cells that surgery may have missed. The other is to monitor the patient with regular brain scans and use radiotherapy if the tumour returns.
The uncertainty existed as strong randomised evidence showing whether immediate radiotherapy actually reduced recurrence had been lacking. The trial helps cement that evidence.
The researchers say that treatment decisions still need to be made jointly by doctors and patients, taking into account possible side effects and the long-term consequences of radiation treatment. Serious radiation-related complications were uncommon in the trial.
The study also did not establish whether the recurrence benefit extends beyond five years. This means that longer follow-up will be needed to gather more evidence. According to the researchers, the findings are expected to shape national and international treatment guidelines.
The options may extend for patients who have undergone complete removal of a WHO grade 2 atypical meningioma. Rather than contemplating “Should we simply watch and wait?”, they can consider moving to a more evidence-based discussion about whether postoperative radiotherapy should be offered upfront.
Credit: iStock
Heart care has been revolutionized in recent decades. New imaging tools, less invasive procedures, implantable devices and digital instruments are allowing doctors to find problems earlier and with more detail. This means that treatment options tend to be more personalized and recovery time can be shortened.
A big part of this shift comes from new tech in heart testing. Doctors can see how big the heart is, what shape it is and how it moves using cardiac CT, MRI and echo. These tests can give specific information on the functioning of the heart. AI is also being looked at for tasks like reading ECG results, analysing heart scans, and tracking patients over time. The American Heart Association says AI may have uses across heart care. At the same time, many tools still need more proof in real clinical settings before they are widely used.
Also read: Don’t Miss a Beat: Why Every Newborn Deserves a Heart Check
Tech is also changing how some heart issues are handled. In the past, some cases needed full open surgery. Now, for certain patients, doctors may use catheter-based or minimally invasive methods instead. Take TAVR as an example. In that approach, a new aortic valve is placed using a catheter. It is positioned inside the older, damaged valve. For the right group of patients, this can avoid open surgery.
Device design is moving forward too. Newer cardiac devices are adding options for people with rhythm problems and other heart conditions. Leadless pacemakers are one example. These devices are meant to support heart rhythm in an effective way while reducing some drawbacks seen with older device types.
Remote monitoring and wearable tools are growing fast. Some devices can track things like heart rate all day. That can reveal issues that someone might not notice on their own. Still, these tools should sit alongside routine checkups. They should not be used to diagnose yourself.
At the end of the day, the goal is not to swap out a cardiologist for a machine. Tech should help doctors gather clearer data. It can also support more accurate procedures. It may even spot disease earlier than before. What treatment makes sense varies from person to person. Doctors weigh age, past health, how bad the condition is, the test results, and the overall level of risk. As new heart devices keep coming, doctors will need solid proof and good judgment about who should use them. That is how new ideas lead to real gains in heart care.
Credit: iStock
She came to the hospital because of a cough that would not go away. The cough was eventually found to be nothing serious. But her CT scan revealed something unexpected — a 12 mm nodule in the outer part of her right lung.
She had never smoked. She felt completely well.
Yet that tiny shadow raised a big question: was it an old tuberculosis scar, a harmless growth, or an early lung cancer?
A CT scan can show us that a nodule is there. It cannot always tell us what it is.
This is an increasingly familiar situation. As CT scans have become more widely used, particularly after the COVID-19 pandemic, doctors are finding small lung nodules in people being scanned for entirely different reasons. Most turn out to be benign. Some, however, need closer assessment.
India has another challenge. Tuberculosis and its scars are common, and a lung shadow can sometimes be attributed to TB without tissue confirmation. While treating tuberculosis promptly is important, assuming that every suspicious nodule is TB can occasionally delay the diagnosis of something else, including cancer.
The answer, when appropriate, is to obtain a tissue sample.
Traditionally, a small nodule deep in the lung could be difficult to reach. A needle biopsy through the chest can be effective but carries a risk of a collapsed lung. Conventional bronchoscopy is excellent for the larger airways but becomes more challenging as the target gets smaller and farther towards the edge of the lung. Surgery may sometimes be necessary.
Navigation bronchoscopy uses the patient's CT scan to create a three-dimensional map of the airways and guide a thin catheter towards the nodule. Cone Beam CT adds real-time three-dimensional imaging during the procedure, allowing the doctor to check where the instruments are in relation to the lesion before taking the biopsy.
In simple terms, navigation helps us find the way; Cone Beam CT helps us confirm we are there.
The tissue can then be examined immediately where appropriate, helping determine whether the sample is adequate and whether additional material is needed for advanced testing.
Importantly, not every nodule needs a biopsy. Many are best managed through carefully planned follow-up scans. The decision depends on the nodule's size and appearance, previous scans, and the patient's overall risk.
For patients, the message is reassuring: a lung nodule does not mean cancer. But it should not be ignored either.
Keep previous scans. Ask what the likely possibilities are. Understand why your doctor recommends surveillance or biopsy — and make sure the follow-up happens.
Today, advanced bronchoscopy is helping doctors turn a worrying shadow into something much more useful: an answer.
(By Dr Shyam Krishnan, Intervention Pulmonologist, CMRI)
© $2026 Times Horizon Private Limited